However, in contrast to the PSMA biomarker, which is expressed only on prostate cancer cells, PTPμ is expressed on endothelial cells and specifically found at cellular junctions which mediate paracellular permeability and potentially extravasation [37,38,39,40]. Here, FOLH1 is linked to prostate carcinoma.